Analyst Ratings for Bristol-Myers Squibb Co. (BMY)Updated: 2017-07-28
Bristol-Myers Squibb Co. (NYSE:BMY) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMY received an average rating of Overweight.
24 analysts issued ratings on the stock, where 10 gave BMY a buy rating, 1 gave an overweight rating, 10 issued a hold rating, 1 issued an underweight rating, and 2 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 1.
Several price targets were given for BMY by the analysts covering the stock. The highest price target was 68, which equates to a potential upside of 25.37 percent. The lowest price target was 40, which equates to a potential downside of -26.25 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.68 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 4.27 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.34 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.53 percent.
People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 3 analysts increased their quarterly estimates, while 4 analysts revised their estimates downwards. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts made negative revisions to their fiscal year's estimates.
Analysts estimate earnings of BMY to grow at a rate of 3.52 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of BMY is 5.6.
In the last 52-weeks, BMY has achieved a high of 76.48 and a low of 46.01. Today's price is 17.89 percent above the 52-week low, and below the high by 29.08 percent. BMY has a P/E ratio of 19.72. Investors typically compare the P/E ratio to a company's peers in the industry. The BMY value stock report compares BMY to some of its peers using value stock charts. The market cap of BMY is $92.22 billion. BMY is estimated to release their earnings results for the quarter on 0000-00-00, days from today.